SMTL ID : 4bks.3 (3 other biounits)

von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-oxazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x X6C: (2S,4R)-1-ethanoyl-N-[[4-(1,3-oxazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)

X6C.1: 11 residues within 4Å: Chain C: F.25, W.37, Y.47, P.48, R.56, I.58, H.59, S.60, Y.61, H.64, W.66 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:W.37, C:Y.47, C:Y.47, C:I.58, C:W.66 Hydrogen bonds: C:W.37, C:R.56, C:H.59, C:Y.61, C:H.64

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dias, D.M. et al., Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?. Acs Med.Chem.Lett. (2014)

Release Date

2013-11-27

Peptides

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2: A
TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1: B
VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

B
H

C
I

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1

VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR

Related Entries With Identical Sequence